• Login
    View Item 
    •   CDR Home
    • Creighton Research and Scholarship including the Faculty Bibliography
    • Faculty Bibliography Database
    • View Item
    •   CDR Home
    • Creighton Research and Scholarship including the Faculty Bibliography
    • Faculty Bibliography Database
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

    Creighton Authors
    Monk, Bradley J.

    Admin. Units
    School of Medicine; Obstetrics and Gynecology; Gynecological Oncology

    Title
    Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

    Authors
    Monk, Bradley J.; Poveda, Andrés; Vergote, Ignace; Raspagliesi, Francesco; Fujiwara, Keiichi; Bae, Duk-Soo; Oaknin, Ana; Ray-Coquard, Isabelle; Provencher, Diane M.; Karlan, Beth Y.; Lhommé, Catherine; Richardson, Gary; Rincón, Dolores G.; Coleman, Robert L.; Herzog, Thomas J.; Marth, Christian; Brize, Arija; Fabbro, Michel; Redondo, Andrés; Bamias, Aristotelis; Tassoudji, Marjan; Navale, Lynn; Warner, Douglas J.; Oza, Amit M.

    Journal
    Lancet Oncology

    Volume
    15

    Issue
    8

    Pages
    799-808

    Date
    2014

    Metadata
    Show full item record
    Link
    Check for Full-Text (may not be available)

    URI
    http://hdl.handle.net/10504/63135
    Citation
    Monk, Bradley J.; Poveda, Andrés; Vergote, Ignace; Raspagliesi, Francesco; Fujiwara, Keiichi; Bae, Duk-Soo; Oaknin, Ana; Ray-Coquard, Isabelle; Provencher, Diane M.; Karlan, Beth Y.; Lhommé, Catherine; Richardson, Gary; Rincón, Dolores Gallardo; Coleman, Robert L.; Herzog, Thomas J.; Marth, Christian; Brize, Arija; Fabbro, Michel; Redondo, Andrés; Bamias, Aristotelis; Tassoudji, Marjan; Navale, Lynn; Warner, Douglas J.; Oza, Amit M. Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial. The Lancet Oncology. 2014, 15(8):799-808.

    Collections
    • Faculty Bibliography Database

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of the CDRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV